Lymphoid Cells

Lymphoid cells provide long-lasting immunity against microbes and pathogens, and play important roles in fields such as autoimmunity and cancer immunotherapies. ATCC offers authenticated lymphoid cells and optimized media products to immunology and oncology researchers.


Our continuous cell lines have been authenticated via multiple methods, including short tandem repeat profiling, cytochrome oxidase barcoding, and microbial contamination testing. The use of human primary lymphoid cells from ATCC further help research obtain clear, confident results by increasing physiological relevance.


Primary Lymphocytes

CD4+ T Cells
CD8+ T Cells
CD19+ B Cells
CD56+ Natural Killer (NK) Cells

ATCC primary lymphocytes have been obtained from multiple donors via institutional review board-approved protocols that follow cGMP and cGTP tissue collection and processing guidelines.


PBMCs and Monocytes

Peripheral Blood Mononuclear Cells
Peripheral Blood CD14+ Monocytes
Bone Marrow Mononuclear Cells

ATCC offers mononuclear cells from peripheral blood (PBMCs) and bone marrow. Mononuclear cells are a heterogeneous population of cells, consisting of lymphocytes (T cells, B cells, NK cells), monocytes, and dendritic cells.

Lymphoid/Leukemic Cell Lines

TF-1
JM-1
K-562
U-937
Daudi
Jurkat, Clone E6-1
RAW 264.7

Lymphoid and leukemic cells originate in the marrow and then migrate into blood circulation, lymphatic circulation, and lymphatic tissues. Highly authenticated and easy-to-grow, these cells can be used at any point in your cancer immunology studies.